Recently, PET ligands binding to synaptic vesicle 2a (SV2a), such as 11C-UCB-J, have been developed, providing a in vivo marker of synaptic density, thought to be a key pathomechanism in PD and PD progression to dementia251. Here, SV2A is linked to Parkinson disease.